Rehabilitation Exercise With MObile Technology and Education After Acute Coronary Syndrome

Acute Coronary Syndrome Clinical Trial

— REMOTE-ACS  

Official title:

Is Tele-rehabilitation an Efficacious Alternative to Traditional Center Based Cardiac Rehabilitation After Acute Coronary Syndrome?

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT05385341
• Other study ID #: RC31/18/0474
• Status: Withdrawn
• Phase: N/A
• Start date: September 1, 2022
• Est. completion date: March 31, 2023

Study information

• Verified date: July 2023
• Source: University Hospital, Toulouse
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Despite a clear indication of grade Ia, cardiac rehabilitation (CR) is dramatically underutilized after acute coronary syndrome with less than 30% of patients addressed in France. Mobile technology has the potential to overcome barriers to access to cardiac rehabilitation and may be a useful tool for increasing participation. However, studies have to prove this type of care is as effective as traditional center based cardiac rehabilitation.

Description:

After acute coronary syndrome (ACS), it is recommended to propose a cardiac rehabilitation (CR) program in order to reduce the risk of recidive, to improve the quality of life and to reduce the risk of disabilities. Traditional CR which is most of the time center-based, is underutilized with less than 30% of patients addressed en France. Therefore, Télé-Cardiac Rehabilitation (Télé-RCV) has been developped progressively since the eighties showing comparable efficacity compared with CR concerning physical fitness. The investigative team, had previously published results showing that telephone support guided by accelerometers could improve physical activity. However, In France, device allowing telemonitoring online of heart rate are not available. Moreover, the investigators have not yet developped remote therapeutic education which is proposed in CR programs. Thus, the present study planned to develop and evaluate aTele-RCV solution aimed to monitor exercise training at home and to educate remotely patient after ACS. The device is an association of a heart rate monitor, a blood pressure testing, a balance linked with a full web secured application connecting patient and caregivers. In the intervention group, Tele-RCV is proposed during 20 sessions containing 2h of exercise training combined with 6h of therapeutic tele-education. In the control group, CR is proposed during 20 sessions with the same volume of exercise training and therapeutic education. After randomisation, patient are allocated to one of the two groups. The evaluation of the primary and secondary outcomes are realized at the beginning, at one month (only walking tests) and at 2 months. A social evaluation is done in parallel to test the acceptability for the Télé-RCV compared with CR.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: March 31, 2023
• Est. primary completion date: March 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 79 Years

Eligibility

Inclusion Criteria:

• Patient with acute coronary syndrome less than 6 months,
• Addressed to ambulatory cardiac rehabilitation,
• Equipped with a smartphone compatible with the protocol's application, connected to web
• Having signed an informed consent,
• Affiliated to the french national health insurance.

Exclusion Criteria:

• Incapacity to use application on smartphone,
• Contraindication to exercise training,
• Pregnancy,
• Juridic protection
• Left ventricular ejection fraction < 45%
• Significate ventricular arrhythmia (frequent or polymorph PVC during initial exercise testing, ventricular tachycardia or sudden cardiac death at the beginning)
• Flutter or atrial fibrillation (transient or permanent)
• Coronary revascularization needing supplementary procedure
• Residual myocardial ischemia determined by initial exercise testing or alternative testing (nuclear imaging or stress echocardiography)
• Mini Mental State < 26
• Patients living alone at home
• Comorbidities limiting participation to the protocol: kidney dialysis, insulin-requiring diabetes, residuals sequels of central and/or peripheral nervous system injuries

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Syndrome

Intervention

Other:
• Telerehabilitation (Tele RCV)
20 home-based sessions monitored by the REMOTE-ACS device and containing 2 hours/day 5 days/7 of exercise training associated with educative sessions.
• Rehabilitation (RCV)
20 sessions of cardiac rehabilitation will be realized in a rehabilitation center containing exercise training during 2 hours/day 5 days/7 and educative program.

Locations

Country	Name	City	State
France	Marc LABRUNEE	Toulouse

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Effect analysis 2 month after inclusion	Change of the peak oxygen volume at 2 months after inclusion	2 months
Secondary	Effect analysis 1 month after inclusion	Analysis of change between T0 and 1 month concerning the walking tests : distance traveled in meters	1 month
Secondary	Effect analysis 1 month after inclusion	Analysis of change between T0 and 1 month concerning the number of Tele-RCV or RCV sessions realized	1 month
Secondary	Effect analysis 2 months after inclusion	Analysis of change between T0 and 2 months concerning the walking tests:distance traveled in meters	2 months
Secondary	Effect analysis 2 months after inclusion	Analysis of change between T0 and 2 months concerning the number of Tele-RCV or RCV sessions realized	2 months
Secondary	Health economics criteria	Incremental Cost-effectiveness ratios of the REMOTE-ACS device compared with the traditional cardiac rehabilitation after acute coronary syndrome according to the French national health insurance perspective and 2 months follow-up period.	26 months
Secondary	Health economics criteria	Cost-utility ratios of the REMOTE-ACS device compared with the traditional cardiac rehabilitation after acute coronary syndrome according to the French national health insurance perspective and 2 months follow-up period.	26 months
Secondary	Production cost of the REMOTE-ACS device	Production cost of the REMOTE-ACS device by micro costing, according the hospital perspective	26 months
Secondary	Acceptability of the device	The acceptability will be assessed by a sociological point of view based on collective meeting (with patient and caregivers) and individual questionnaires for the two groups before randomization and after the program only for the Tele-RCV group.	26 months
Secondary	Satisfaction of the device	The satisfaction will be assessed by a questionnaire of satisfaction titled: Cardiovascular rehabilitation program satisfaction questionnaire, with 8 questions, the minimum value is "nothing", and the maximum value is "very important"	26 months